Outcomes of repeat descemetopexy in post-cataract surgery descemet membrane detachment.
OBJECTIVE
To assess the outcomes of repeat descemetopexy in post-cataract surgery Descemet membrane detachment.


METHODS
Retrospective interventional case series.


METHODS
This multicenter, institutional study done between January 2007 and July 2013 included 13 eyes of 13 patients who underwent repeat descemetopexy after a failed initial procedure in post-cataract surgery Descemet membrane detachment. Patients without a minimum follow-up of 1 month were excluded. They underwent repeat descemetopexy with either 100% air or isoexpansile mixture of 14% C3F8. At 1 month, final status of Descemet membrane, final best-corrected visual acuity (BCVA), and incidence of postsurgical complications were noted.


RESULTS
Mean age was 63.7 ± 6.6 years; male-to-female ratio, 8:5. Descemet membrane detachment involved the visual axis in all cases. Mean interval between 2 interventions was 5.1 ± 3.1 days. Same gas was used in 9 of 13 patients (air, 4; C3F8, 5). Air was used earlier and C3F8 later in 4 patients. At 1 month, 12 of 13 patients had an attached Descemet membrane and improved mean logMAR BCVA (P = .0036). One case developed postoperative pupillary block and 1 case required endothelial transplantation.


CONCLUSIONS
Repeat descemetopexy for post-cataract surgery Descemet membrane detachment gives good anatomic and visual results and is definitely a worthwhile attempt before a complex surgical procedure like keratoplasty is offered.
Cornea Services, L. V. Prasad Eye Institute, Bhubaneswar, Odisha, India. Electronic address: drrajat.ophth@gmail.com.
Rajat
R
Jain
Vitreo-Retina Services, L. V. Prasad Eye Institute, Bhubaneswar, Odisha, India.
Neha
N
Mohan
D000368:Aged; D000388:Air; D002387:Cataract Extraction; D003316:Corneal Diseases / Q000175:diagnosis / Q000209:etiology / Q000601:surgery*; D003886:Descemet Membrane / Q000473:pathology / Q000601:surgery*; D058450:Endotamponade / Q000379:methods*; D005260:Female; D005466:Fluorocarbons / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D012086:Reoperation; D012189:Retrospective Studies; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome; D014792:Visual Acuity
D005466:Fluorocarbons; C042852:perflutren